机构:[a]The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China广东省中医院[b]Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China广东省中医院[c]Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China[d]Chinese GRADE Center, Lanzhou, China[e]WHO Collaborating Centre for Guideline Implementation and Knowledge Translation, Lanzhou, China[f]Standardization Project Management Office of China Association of Traditional Chinese Medicine, Beijing, China[g]The First Affiliated Hospital of Guangzhou Medical University, The First Clinical School of Guangzhou Medical University, Guangzhou, China[h]Guangzhou Institute of Respiratory Disease, Guangzhou, China[i]State Key Laboratory of Respiratory Disease, Guangzhou, China[j]National Clinical Research Center for Respiratory Disease, Guangzhou, China
the Project of Clinical Guideline on
CPMs for Dominant Diseases of National Administration of Traditional
Chinese Medicine (grant number SATCM-2015-BZ402-015); National
Natural Science Foundation of China (grant number81503676); and
Science and Technology Planning Project of Guangdong Province (grant
number 2017A020213007).
第一作者机构:[a]The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China[b]Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China
共同第一作者:
通讯作者:
通讯机构:[a]The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China[b]Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China[g]The First Affiliated Hospital of Guangzhou Medical University, The First Clinical School of Guangzhou Medical University, Guangzhou, China[h]Guangzhou Institute of Respiratory Disease, Guangzhou, China[i]State Key Laboratory of Respiratory Disease, Guangzhou, China[j]National Clinical Research Center for Respiratory Disease, Guangzhou, China
推荐引用方式(GB/T 7714):
Lei Wu,Yaolong Chen,Yanfang Ma,et al.Clinical Practice Guideline on Treating Influenza in Adult Patients with Chinese Patent Medicines.[J].PHARMACOLOGICAL RESEARCH.2020,160:doi:10.1016/j.phrs.2020.105101.
APA:
Lei Wu,Yaolong Chen,Yanfang Ma,Zifeng Yang,Nan Yang...&Lin Lin.(2020).Clinical Practice Guideline on Treating Influenza in Adult Patients with Chinese Patent Medicines..PHARMACOLOGICAL RESEARCH,160,
MLA:
Lei Wu,et al."Clinical Practice Guideline on Treating Influenza in Adult Patients with Chinese Patent Medicines.".PHARMACOLOGICAL RESEARCH 160.(2020)